UniSA's weekly injectable gel delivers levodopa and carbidopa, potentially transforming Parkinson's care for 8.5M people by simplifying treatment and reducing side effects.

CREXONT ® is a novel, oral formulation of carbidopa/levodopa (CD/LD) capsule that combines both immediate-release granules and extended-release beads for the treatment of Parkinson’s disease.

Scientists have developed a long-acting injectable treatment combining levodopa and carbidopa, the two medications used to treat Parkinson’s, which could transform how the disease is treated.

CREXONT® is a novel, oral formulation of carbidopa/levodopa (CD/LD) capsule that combines both immediate-release granules and extended-release beads for the treatment of Parkinson’s disease.

Research shows promising results for a weekly injectable Parkinson's treatment that maintains consistent medication levels, possibly eliminating multiple daily pills.

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets.

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets.

Becker’s is pleased to release the 2025 edition of its “Great community hospitals” list.Community hospitals play a vital role in the fabric of the U.S. healthcare system, delivering ...

Former NBA guard Ben McLemore was sentenced to 100 months in prison after being found guilty of raping a 21-year-old woman in Oregon, as prosecutors praised the victim's courage.

"The Top 100 Players of 2025" -- voted on by the players themselves -- is underway on X and NFL+! Find out which players ranked Nos. 90-81.

In patients with wearing off fluctuations who are taking more than 600 mg IR levodopa or who have dyskinesias, it is recommended to use add-on entacapone, titrate levodopa as needed, then switch ...

Sabrina Carpenter’s “Manchild” soars onto the Billboard Hot 100 at No. 1. The song is her second leader, and first to debut in the top spot.